Skip to main content
Gaurav Shah, DO, Cardiology, Aurora, IL

GauravBipinShahDO

Cardiology Aurora, IL

Cardiac Electrophysiology

Physician

Overview of Dr. Shah

Dr. Gaurav Shah is a cardiologist in Aurora, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center, Rush-Copley Medical Center, Rush-Copley Medical Center, Loyola University Medical Center, and AMITA Health Mercy Medical Center. He received his medical degree from Des Moines University College of Osteopathic Medicine and has been in practice 11 years. He is one of 859 doctors at Loyola University Medical Center and one of 27 doctors at AMITA Health Mercy Medical Center who specialize in Cardiology.

Education & Training

  • Advocate Health Care/Advocate Lutheran General Hospital
    Advocate Health Care/Advocate Lutheran General HospitalResidency, Internal Medicine, 2006 - 2009
  • Des Moines University College of Osteopathic Medicine
    Des Moines University College of Osteopathic MedicineClass of 2006

Certifications & Licensure

  • IL State Medical License
    IL State License 2008 - 2026
  • MI State Medical License
    MI State License 2010 - 2016
  • WI State Medical License
    WI State License 2009 - 2012
  • AOA Board of Internal Medicine Cardiology
  • AOA Board of Internal Medicine Interventional Cardiology (CAQ)

Press Mentions

  • Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data and Presents at Late-Breaking Scientific Sessions at 2024 American Heart Association Conference
    Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data and Presents at Late-Breaking Scientific Sessions at 2024 American Heart Association ConferenceNovember 18th, 2024
  • Rush Copley Named One of Best Hospitals for Treating Heart Attacks
    Rush Copley Named One of Best Hospitals for Treating Heart AttacksJuly 22nd, 2024
  • Rocket Pharmaceuticals Announces Clearance of IND for RP-A501 Gene Therapy for Danon Disease
    Rocket Pharmaceuticals Announces Clearance of IND for RP-A501 Gene Therapy for Danon DiseaseJanuary 22nd, 2019
  • Join now to see all

Professional Memberships